Skin Cancer

Latest News

August 6th 2026

After Wild Ride, FDA Grants Accelerated Approval for Replimune’s RP1 Plus Nivolumab in Advanced Melanoma

Accelerated approval is granted to RP1 plus nivolumab for advanced melanoma after PD-1 failure, following a nail-biting FDA approval process.

A Moderna lab professional works on mRNA discoveries. | Image: Moderna media gallery

July 27th 2026

The Promise and Politics of Creating mRNA Vaccines in Cancer

By Ryan Flinn

June 7th 2026

Immunotherapy Increases Melanoma Survival, Yet Toxicity Gaps Persist: Igor Puzanov, MD, MSCI, FACP

By Brooke McCormick, Igor Puzanov, MD, MSCI, FACP , Ella Hohmann, MS

DNA in test tube | Image Credit: Connect world - stock.adobe.com

May 28th 2026

Familial Melanoma Genes May Have Broader Cancer Impact Than Previously Recognized, Study Finds

By Brooke McCormick

Global health | Image Credit: Khongtham - stock.adobe.com

May 18th 2026

Global Skin Cancer Burden Projected to Rise Sharply Through 2050, Especially in Low-, Middle-Income Regions

By Brooke McCormick

Latest Videos

Focus Shifts to Toxicity Management Gaps as Melanoma Survival Improves: Igor Puzanov, MD, MSCI

Balancing Efficacy and Tolerability in Skin Cancer Treatment: Todd Schlesinger, MD

High UV Exposure Tied to Elevated Melanoma Risk in Large NIH-AARP Study: Samer Wahood, AB

Neil Gross, MD, FACS, MD Anderson Cancer Center

Dr Neil Gross: Cemiplimab Has Great Potential in cSCC

Dr Neil Gross on Potential Impact of Future Novel Treatments for cSCC

Dr Neil Gross Discusses the Implications of pCR on Additional Treatment in Skin Cancer

Dr Neil Gross: QOL Improvement Likely Following Treatment With Cemiplimab for cSCC

Dr Neil Gross: Cemiplimab Is Producing Encouraging Results in Resectable cSCC

Dr Christine Ko on Making Tough Skin Cancer–Related Decisions for Transplant Patients

Todd Schlesinger, MD, FAAD, Dermatology and Laser Center of Charleston, Clinical Research Center of the Carolinas

Dr Todd Schlesinger: Tissue-Sparing Mohs Surgery Is Highly Accurate

Shorts

0:32

How SkinIO's Full Body Scan Caught Melanoma: Steve Bonner

2 months ago

by

Giuliana Grossi

2:14

Multidisciplinary Care, Early Detection Key to Managing Immunotherapy Effects in Melanoma: Igor Puzanov, MD, MSCI, FACP

3 months ago

by

Brooke McCormick(+2 more)

2:31

Melanoma Survival Gains Highlight Next Frontier in Immunotherapy: Igor Puzanov, MD

3 months ago

by

Brooke McCormick(+2 more)

1:08

Proactive AE Management Sustains Skin Cancer Treatment Benefits: Todd Schlesinger, MD

6 months ago

by

Brooke McCormick(+2 more)

More News

Burn scar | Image Credit: Africa Studio - stock.adobe.com

Burn Scar–Related Skin Cancers Associated With High Recurrence, Mortality Risk

ByBrooke McCormick

May 14th 2026

Skin cancers arising from burn scars carry high recurrence and mortality risks, with squamous cell carcinoma considered most common.

Melanoma | Image Credit: lavizzara - stock.adobe.com

ctDNA Shows Prognostic Value in Resectable Melanoma, but Sensitivity Gaps Limit Clinical Utility

By